Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-24T14:32:22.375Z Has data issue: false hasContentIssue false
  • English
  • Français

A paediatric case of myopericarditis post-COVID-19 mRNA vaccine

Part of: Infectious

Published online by Cambridge University Press:  27 January 2022

Mehmet Türe Open the ORCID record for Mehmet Türe [Opens in a new window] ,
Alper Akın Open the ORCID record for Alper Akın [Opens in a new window] ,
Muhammed Demir  and
Cihan Akay
Mehmet Türe*
Affiliation:
Department of Pediatric Cardiology, Dicle University Hospital, Diyarbakır, Turkey
Alper Akın
Affiliation:
Department of Pediatric Cardiology, Dicle University Hospital, Diyarbakır, Turkey
Muhammed Demir
Affiliation:
Department of Cardiology, Dicle University Hospital, Diyarbakır, Turkey
Cihan Akay
Affiliation:
Department of Pediatric, Dicle University Hospital, Diyarbakır, Turkey
*
Author for correspondence: Mehmet Türe, MD, Pediatric Cardiologist, Department of Pediatric Cardiology, Dicle University Hospital, Diyarbakır, Turkey. Tel: +90 412 2488001. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Myopericarditis is a condition, which primarily involves the pericardium, with minimal myocardial involvement. In myopericarditis, chest pain, elevated cardiac enzymes, and electrocardiographic changes occur. Although COVID-19 mRNA vaccines significantly contribute to preventing the COVID-19 disease, rarely myocarditis and/or pericarditis may develop due to these vaccines. We present a previously healthy 14-year-old male patient who developed myopericarditis after receiving the second dose of the COVID-19 mRNA vaccine.

Keywords

mRNA vaccinesmyopericarditisCOVID-19
Type
Brief Report
Information
Cardiology in the Young , Volume 32 , Issue 10 , October 2022 , pp. 1688 - 1691
Check for updates
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Spodick, DH. Myopericarditis/perimyocarditis. The Pericardium. Marcel Dekker, Inc, New York, 2001, 114–125.Google Scholar
Dec, GW Jr, Waldman, H, Southern, J, Fallon, JT, Hutter, AM Jr, Palacios, I. Viral myocarditis mimicking acute myocardial infarction. J Am Coll Cardiol 1992; 20: 85–89.CrossRefGoogle ScholarPubMed
Kime, P. Pentagon Tracking 14 cases ofHeart Inflammation in Troops after COVID-19 Shots. Military.com, 26 April 2021.Google Scholar
Imazio, M, Cecchi, E, Demichelis, B, et al. Indicators of poor prognosis of acute pericarditis. Clinical features for pericarditis triage. Circulation 2007; 115: 2739–2744.CrossRefGoogle Scholar
Halsell, JS, Riddle, JR, Atwood, JE, et al. Myopericarditis following smallpox vaccination among vaccinia-naïve US military personnel. JAMA 2003; 289: 3283–3289.CrossRefGoogle ScholarPubMed
Imazio, M, Trinchero, R. Clinical management of acute pericardial disease: a review of results and outcomes. Ital Heart J 2004; 5: 803–817.Google ScholarPubMed
AAP News. Retrieved June 18, 2021, from https://www.aappublications.org/news/2021/06/10/covid-vaccine-myocarditis-rates-061021 Google Scholar
Dalgaard, JB. Fatal myocarditis following smallpox vaccination. Am. Heart J 1957; 54: 156–157.CrossRefGoogle ScholarPubMed
Recent Update on mRNA Vaccine. Retrieved June 26, 2021, from https://www.cdc.gov/vaccines/acip/meetings/slides-2021-06.html Google Scholar
Montgomery, J., Ryan, M., Engler, R., et al. Myocarditis following immunization with mRNA COVID-19 vaccine in memebrs of the US military. JAMA Cardiol 2021; 6: 1202–1206.CrossRefGoogle ScholarPubMed
Das, BB, Moskowitz, WB, Taylor, MB, Palmer, A. Myocarditis and pericarditis following mRNA COVID-19 vaccination: What do we know so far? Children (Basel) 2021; 8: 607.Google ScholarPubMed